(I still have significant neuropathy with lesions on my spinal cord ... which is substantially more resistant to acyclovir and related drugs. When it comes to whether acyclovir needs to be stopped, I ...
Investment analysts at StockNews.com initiated coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Wednesday. The firm set a “hold” rating on the biopharmaceutical ...